本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

武田製藥

14.43
-0.3100-2.10%
盤後14.430.00000.00%16:53 EDT
成交量:364.40萬
成交額:5,289.97萬
市值:455.73億
市盈率:64.28
高:14.72
開:14.72
低:14.41
收:14.74
資料載入中...
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/28

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/09

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/21

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals